» Authors » Patricia Griffin

Patricia Griffin

Explore the profile of Patricia Griffin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 312
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaye A, Islam R, Castine A, Wester G, Barham W, Nguyen C, et al.
Cureus . 2025 Mar; 17(2):e78731. PMID: 40065888
The interplay between psychiatric conditions and dermatological disorders is complex and multifaceted, often resulting in significant challenges for both diagnosis and treatment. This narrative review examines associations between specific psychiatric...
2.
Arata W, Midha R, Varrassi G, Sala K, Plessala M, Brodtmann J, et al.
J Oral Facial Pain Headache . 2025 Jan; 38(2):1-10. PMID: 39801092
The occipital nerve block involves the injection of a local anesthetic and possibly a corticosteroid near the occipital nerves at the base of the skull and aims at providing relief...
3.
Jones K, Hayden S, Meyer H, Sandoz J, Arata W, Dufrene K, et al.
Curr Issues Mol Biol . 2024 Jul; 46(7):6315-6327. PMID: 39057019
Worldwide, hypertension is the leading risk factor for cardiovascular disease and death. An estimated 122 million people, per the American Heart Association in 2023, have been diagnosed with this common...
4.
Griffin P, Hill W, Rossi F, Boohaker R, Stinson K, Sherman I
Cancer Cell Int . 2023 Apr; 23(1):60. PMID: 37016369
The alpha-fetoprotein receptor (AFPR) is a novel target for cancer therapeutics. It is expressed on most cancers and myeloid derived suppressor cells (MDSCs) but generally absent on normal tissues. Studies...
5.
Vallejo A, Mroczkowski H, Michel J, Woolford M, Blair H, Griffin P, et al.
Clin Transl Immunology . 2021 Jul; 10(6):e1304. PMID: 34194748
Objectives: Very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a disorder of fatty acid oxidation. Symptoms are managed by dietary supplementation with medium-chain fatty acids that bypass the metabolic block. However, patients...
6.
Ferguson I, Griffin P, Michel J, Yano H, Gaffen S, Mueller R, et al.
Front Immunol . 2018 Aug; 9:1802. PMID: 30127787
T cells are considered autoimmune effectors in juvenile idiopathic arthritis (JIA), but the antigenic cause of arthritis remains elusive. Since T cells comprise a significant proportion of joint-infiltrating cells, we...
7.
Barton D, Shuster L, Dockter T, Atherton P, Thielen J, Birrell S, et al.
Support Care Cancer . 2017 Nov; 26(4):1335-1343. PMID: 29164377
Background: Dehydroepiandrosterone (DHEA) is helpful for treating vaginal symptoms. This secondary analysis evaluated the impact of vaginal DHEA on hormone concentrations, bone turnover, and vaginal cytology in women with a...
8.
Barton D, Sloan J, Shuster L, Gill P, Griffin P, Flynn K, et al.
Support Care Cancer . 2017 Sep; 26(2):643-650. PMID: 28921241
Background: Women with estrogen deficiencies can suffer from vaginal symptoms that negatively impact sexual health. This study evaluated vaginal dehydroepiandrosterone (DHEA) for alleviation of vaginal symptoms. Methods: This three-arm randomized,...
9.
Michel J, Griffin P, Vallejo A
Front Immunol . 2016 Dec; 7:530. PMID: 27933066
The fundamental challenge of aging and long-term survivorship is maintenance of functional independence and compression of morbidity despite a life history of disease. Inasmuch as immunity is a determinant of...
10.
Dvergsten J, Mueller R, Griffin P, Abedin S, Pishko A, Michel J, et al.
Arthritis Rheum . 2013 May; 65(8):2201-10. PMID: 23686519
Objective: CD8+ T cells lacking CD28 were originally reported to be a characteristic feature of juvenile idiopathic arthritis (JIA), but the relevance of these unusual cells to this disease remains...